In humans, CTGF levels are elevated in patients with fibrotic lung disease, including idiopathic pulmonary fibrosis (IPF), bronchopulmonary dysplasia, sarcoidosis, and systemic sclerosis [6, 13–18]. Here, CCN2 is linked to idiopathic pulmonary fibrosis.